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Outline of this thesis 
 
The experiments described in this thesis have been performed in order to gain more 
information about the recognition of Schistosoma mansoni glycans of 
glycosphingolipids or glycoproteins by the C-type lectins DC-SIGN and L-SIGN. 
In chapter 1 an introduction in the topic concerning schistosomes, their manifold 
glycoconjugates, expressed as glycoproteins and glycosphingolipids, as well as the 
immunobiology of schistosome infection is presented. Moreover, the C-type lectins 
DC-SIGN and L-SIGN are introduced and the multiple roles of carbohydrates during 
the immune response to schistosome infection are addressed.  
In chapter 2 the original publications resulting from this work are displayed. In the 
first publication (Meyer et al. JBC 2005) we demonstrated that besides the Lewis X 
epitope also the pseudo-Lewis Y motif, both of which are expressed on cercarial 
glycosphingolipids of schistosomes, are ligands of DC-SIGN. The pseudo-Lewis Y 
moiety is the first parasite-specific ligand described for this lectin.  
In the second publication, a quick method for biotinylation of oligosaccharides is 
presented allowing a fast analysis of carbohydrate-lectin interactions.  
In the third publication (Meyer et al. Glycobiology 2007) we demonstrated that the 
C-type lectin L-SIGN has a broad ligand specificity recognizing high-mannose 
structures on SEA as well as fucosylated glycolipids of schistosome eggs carrying 
the F-LDN-F epitope. 
In chapter 3 the results presented in this thesis are integrated in a general discussion 
including a future outlook concerning this topic of research. 
Finally, in chapter 4 and 5 a summary of this work is given in English and German.
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Introduction 1
1 Introduction and literature overview 
1.1 The parasite Schistosoma mansoni 
1.1.1 Zoological classification of schistosomes 
Within the helminths, i.e. parasitic metazoans classified in the clades plathelminthes, 
nematodes and acanthocephala, schistosomes belong to the first named clade and to 
the class of trematodes. They are summarized to the family of schistosomatidae 
which consists of 12 genuses, all of which live parasitically in the blood vessels of 
vertebrates (121). Humans are mainly infected by S. mansoni, S. haematobium, 
S. japonicum, S. mekongi and S. intercalatum. 
1.1.2 Life cycle of Schistosoma mansoni  
The life cycle of schistosomes alternates between an asexual phase in the 
invertebrate host, a freshwater snail, and a sexual generation in the vertebrate host. 
Due to these switches between hosts and the way of reproduction, the life cycle of 
schistosomes belongs to the most complex ones in the whole animality. An overview 
of the life cycle of S. mansoni is depicted in Figure 1. A schistosome egg hatches in 
fresh water, releasing a motile larva, the miracidium. Within eight to twelve hours 
the miracidium has to find its intermediate host, in the case of S. mansoni a 
freshwater snail of the genus Biomphalaria. After invasion of the snail the 
miracidium develops into the mother sporocyst and, via the open circulation system, 
daughter sporocysts reach the mid-gut-gland and continue the further development 
resulting in the release of cercariae. Four to six weeks after snail infection, the 
cercariae hatch in response to light attraction. These human pathogenic larvae, being 
equipped with a bifurcated tail, actively search for their definitive host, penetrate his 
skin, release their tails and transform to schistosomula. This transformation is 
accompanied by profound changes in their metabolism and antigenic structures at 
their surface (59; 60; 86). Schistosomula dwell in the human skin for two to three 
days and migrate afterwards in the blood vessels und reach the lungs. After several 
days they continue their way via the blood stream to the mesenterial veins and into 
the liver. After maturation to adult worms, male and female worms pair and migrate 
against the blood stream into the intestinal venules of the portal drainage, where they 
permanently settle using their oral sucker. Four to five weeks post infection female 
worms start with egg production (135). Schistosomal couples produce up to three 
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hundreds of eggs per day and their intended fate is to pass from their intravascular 
site of deposition to the intestinal lumen, from where they can leave the body. The 
eggs reaching fresh water release miracidia, which can find and invade the aquatic 
snail host (Figure 1). An alternative dead-end street for the eggs is that they are 
caught by the bloodstream and brought to distal tissue sites in which they become 
trapped. The tissue in which half or even more of the eggs of S. mansoni are captured 
is the liver, as the sinusoids of which are of insufficient diameter to allow the eggs to 
pass. Eggs lodged in the liver, as well as in the intestine, induce strong granuloma 
formation (114). 
 
Figure 1: The life cycle of Schistosoma mansoni (modified after (35)). 
Infection of humans is initiated by cercariae which penetrate the skin, transform into 
schistosomula, enter the vasculature and migrate to the portal system, where they 
mature to adult worms. The eggs produced are released within the vasculature, cross 
the endothelium of the veins and transverse to the epithelium of the intestine. After the 
eggs have reached fresh water, free swimming larvae, called miracidia hatch, which 
actively seek their intermediate host Biomphalaria glabrata. Asexual reproduction 
steps lead to production of infective cercariae. 
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1.2 The disease Schistosomiasis 
 
Many publications on schistosome research begin with the phrase “Schistosomiasis 
is a parasitic disease affecting over 200 million people in 74 countries of the 
developing world”. Perhaps the frequent use of this quotation has made us 
thoughtless about the fact, that among human parasitic diseases, schistosomiasis 
ranks second behind malaria in terms of socio-economic and public health 
importance in tropical and subtropical areas. Of the 200 million people infected, 20 
million suffer from severe consequences of the disease. An estimated number of 500 
to 600 million people worldwide are at risk to get infected. Nowadays, the treatment 
of schistosomiasis depends primarily on chemotherapy using praziquantel ((RS)-2-
(Cyclohexylcarbonyl)-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1] isochino-lin-4-on), 
an isoquinoline-pyrazine derivative with a wide antiparasitic effect. The exact 
mechanism of action of praziquantel is still not known, but it leads to an opening of 
calcium channels at the surface of the adult worm, resulting in a paralysis of the 
parasites. Unfortunately, there is increasing evidence for an emerging drug 
resistance. Due to rather unspecific symptoms, the diagnosis of schistosomiasis is 
still not easy. Therefore, direct and indirect methods have to be employed. One easy 
way is the identification of species-specific parasitic eggs in the stool. A further 
direct diagnostic tool is the detection of circulating cathodic antigen (CCA) and 
circulating anodic antigen (CAA) (see paragraph 1.3 for details) (1; 6; 29-31). 
Indirect methods to diagnose schistosomiasis are, e.g., the detection of hemoglobin in 
the urine (26) or the verification of schistosome-specific antibodies in the serum 
(169).  
The main pathology of a schistosome infection resides in a pronounced 
hepatosplenomegaly (enlargement of spleen and liver), caused by schistosome eggs. 
The female worms deposit several hundreds of eggs per day for up to 30 years (50). 
As outlined above, about up to two third of the eggs fail to adhere to the endothelium 
and become trapped in the hepatic capillary bed. Embolized eggs die within 20 days, 
initiate a local immunpathological reaction and lead to granuloma formation. The 
dieing eggs secrete large amounts of proteins, glycoproteins and glycolipids, which 
are highly antigenic and stimulate the immune response. Before reviewing the 
immunology of schistosomes in more detail (see paragraph 1.4), the major 
glycoconjugates of schistosomes will be described. 
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1.3 Glycoconjugates of schistosomes 
 
Schistosome glycoconjugates play an eminent role in the parasite’s biology, in 
particular, in the interaction with and the survival within the host. It has been shown 
that carbohydrate determinants are major targets of the immune response (38). 
Furthermore, surface-expressed glycans provide the basis for direct diagnostic 
methods (29). An enormous amount of structural data regarding the glycosylation of 
different schistosomal life stages has been collected in the last decades. It became 
evident that the parasites express a great variety of carbohydrate structures, including 
both host-like structural elements and highly antigenic, parasite-specific 
determinants.  
1.3.1 N-glycans of S. mansoni 
Schistosomal glycoproteins contain complex glycan moieties linked via N- or O-
glycosidic linkage to the polypeptide backbone (32; 166). The major structural 
features of these glycoprotein-glycans can be summarized as follows: Glycoproteins 
of S. mansoni adult worms contain typical N-linked oligomannose structures also 
occurring in many eukaryotes (111). In addition, diantennary complex-type 
N-glycans from adult worms carry terminal GalNAcβ1-4GlcNAc (LDN) and 
GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F) elements (112; 129). Moreover, adult worm 
glycoproteins may carry repeating units of Galβ1-4(Fucα1-3)GlcNAc (Lewis X, LeX) 
on multi-antennary N-glycans. Finally, a large proportion of N-glycans of S. mansoni 
adult worms has been shown to represent non-fucosylated, or core-(α1-6)-
fucosylated paucimannosidic structures (79; 110). In particular complex-type glycans 
have been ascribed a vast structural variety (77). Complex-type species may contain 
two LDN antennae, both of which can be fucosylated (129). Alternatively, N-glycans 
may consist of 2-4 N-acetyllactosamine antennae with additional oligomeric Lewis X 
epitopes (128).  
Glycoproteins from S. mansoni eggs contain high-mannose type glycans similar to 
those from adult worms and complex type glycans with Galβ1-4GlcNAc (LN) as 
well as LDN elements. Egg glycoproteins further express truncated N-glycan core 
structures carrying β2-linked xylose and α3-linked fucose residues, which are also 
described for other helminths, insects and even plants (62; 130). In addition, terminal 
(HexNAc)3 epitopes were found in the egg N-glycans with oligofucosyl-units 
attached to the terminal HexNAc residue (78).  
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While the glycosylation of soluble egg antigens (SEA) is thought to play an 
important role in schistosome immunology, data regarding the precise structures of 
the respective glycoprotein-glycans expressed are still incomplete (43; 166). Until 
now three glycoproteins were purified from SEA, named α-1, Ω-1 and κ-5 (34; 36). 
Ω-1 is a secreted, cytotoxic ribonuclease (46), whereas α-1 is identical to a highly 
immunogenic, secreted egg glycoprotein termed IPSE (=interleukin-4-inducing 
principle from S. mansoni eggs) (122). IPSE is a general activator of human 
basophiles triggering the release of IL-4, IL-13 and histamine. Monomeric IPSE 
carries core-difucosylated, diantennary N-glycans with one or more Lewis X motifs 
(161). 
N-glycans of S. mansoni cercariae are mainly hybrid-type or diantennary structures 
with Lewis X trisaccharide units in terminal positions (166). They are core-(α1-6)-
fucosylated throughout and carry often a (β1-2)-core bound xylose (79). 
An overview of typical carbohydrate epitopes present on N-glycans of S. mansoni 
glycoproteins of eggs, cercariae and adult worms is given in Figure 2. 
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Figure 2. Glycoprotein-N-glycans of S. mansoni cercariae, adults and eggs.  
 
In the egg stage the pentasaccharid-core can be up to twofold fucosylated and can be 
modified with β1-2-linked Xylose. Terminal Lewis X and LDN-F units are boxed and 
circled, respectively. 
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1.3.2 O-glycans of S. mansoni  
Schistosome O-glycans range from single O-linked GlcNAc residues or short Galβ1-
3GalNAcα mucin-type disaccharides on glycoproteins from schistosomula or adult 
worms (111) to complex multiply fucosylated glycans from the highly immunogenic 
cercarial glycocalyx (80). These complex O-glycans contain specific epitopes of 
repeating GalNAcß1-4GlcNAcß1-3Galα1-3 units carrying oligofucosyl chains 
(Fucα1-2)0/1Fucα1-2Fucα1-3 motifs linked to the internal GlcNAc, as well as 
terminal (Fucα1-2)0-1Fucα1-3GalNAc structures (Figure 3). These multimeric 
glycans have been shown to be based on conventional type 1 and 2 core structures 
(66; 80). A second group of cercarial O-glycans is based on a novel core-structure 
comprising an O-linked GalNAc with β-linked Gal residues in both 3- and 6-
positions (67). Studies on O-glycosylation in adult worms revealed the presence of 
O-linked Tn-antigens (GalNAcα1-Ser/Thr), T-antigen (Galβ1-3GalNAcα1-Ser/Thr), 
and O-linked GlcNAc (23; 109). So far, only a few publications describe 
carbohydrate structures of purified glycoproteins from adult worms. Well-
characterized examples are the two major gut-associated excreted antigens CCA 
(circulating cathodic antigen) and CAA (circulating anodic antigen) (12; 140). CCA 
carries mainly long, linear multimers of Lewis X trisaccharides and the highly 
negatively charged O-glycans of CAA comprise a polymeric (β1-6)-linked GalNAc 
backbone which is substituted by (β1-3)-linked glucuronic acid (GlcA) residues 
(140). The structures of S. mansoni O-glycans from CAA and CCA are given in 
Figure 3.  
An overview of characteristic glycan epitopes of schistosome glycoproteins and their 
stage-specific occurrence is listed in Table 1. 
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Figure 3. O-glycans of CAA and CCA from S. mansoni adult worms and 
O-glycans of cercariae.  
 
O-glycans of CAA express poly-Lewis X motifs and the O-glycans of CAA carry (β1-3)-
bound glucuronic acid (GlcA). Present Lewis X motifs are boxed. 
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Table 1. Common glycan antigens of S. mansoni and their distribution in the different life-
cycle stages cercariae (C), adults (A) and eggs (E). Glycan epitopes occurring also in 
humans (H) are marked for comparison. Structure plots were generated in the notation of the 
Consortium for Functional Glycomics (http://www.functionalglycomics.org) using the visual 
editor of "GlycoWorkbench". This software application is developed and available as part of 
the EUROCarbDB project (http://www.eurocarbdb.org/applications/ms-tools). Symbols used 
are: light square, GalNAc; dark square, GlcNAc; triangle, Fuc; light circle, Gal. 
 
Carbohydrate 
epitope 
 
Structure 
 
Structure plot 
 
C 
 
A 
 
E 
 
H 
 
LacdiNAc 
(LDN) 
 
GalNAcβ1-4GlcNAc 
 
 
 
+ + + +
 
Terminally 
fucosylated  
LDN (F-LDN) 
 
Fucα1-3GalNAcβ1-
4GlcNAc 
 
 
+ + + -
 
Fucosylated LDN 
(LDN-F) 
 
GalNAcβ1-4(Fucα1-
3)GlcNAc  
+ + + +
 
Fucosylated LDN-F 
(F-LDN-F) 
 
Fucα1-3GalNAcβ1-
4(Fucα1-3)GlcNAc 
 
 
+ + + -
 
Difucosylated 
LDN 
(LDN-DF) 
 
GalNAcβ1-4(Fucα1-
2Fucα1-3)GlcNAc 
 
+  + -
 
Fucosylated  
LDN-DF 
(F-LDN-DF) 
 
Fucα1-3GalNAcβ1-
4(Fucα1-2Fucα1-
3)GlcNAc 
    
+ + + -
 
Lewis X 
(LeX) 
 
Galβ1-4(Fucα1-
3)GlcNAc 
 
 
+ + + +
 
Pseudo-Lewis Y 
(pseudo-LeY) 
 
Fucα1-3Galβ1-
4(Fucα1-3)GlcNAc 
 
+ - - -
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1.3.3 Glycosphingolipids of S. mansoni  
While mammalian glycosphingolipids are based on lactosylceramide (Galβ1-4Glcβ1-
1-ceramide) schistosomal glycolipids carry the so-called “schisto-core” (GalNAcβ1-
4Glc-ceramide) (Figure 4) (98; 165).  
 
 
Figure 4. The “schisto-core”.  
Graphic representation of sugar  moieties with symbols as in Table 1. 
 
Besides simple glucosyl- and galactosylceramides, this schisto-specific 
glycosphingolipid seems to be expressed in all life-cycle stages, nevertheless 
exhibiting strong variations in the ceramide part (164). Elongation of this 
schisto-core leads to very complex glycans including either structural elements 
occurring also in N- or O-glycans, or specific modifications which are found so far 
only on glycolipids. In the context of these more complex S. mansoni glycolipids, 
epitope-typing, using mAb and infection sera, revealed a marked antigenicity and a 
stage-specific expression of individual classes of glycolipid species (160). A 
summary of S. mansoni glycolipids and their occurrence in different life-cycle stages 
is depicted in Figure 5. 
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Figure 5. Summary of S. mansoni glycolipids and their reported stage-specific 
occurrence (modified after (166)).  
 
The three fucose-containing carbohydrate-motifs Lewis X (box), Pseudo-Lewis Y 
(dotted box) and M2D3H (dashed box) are indicated. The occurrence in each life-cycle 
stage is listed. Ad, adult worms; Ce, cercariae; Egg, eggs. 
 
Cercarial glycolipids were shown to be based on the schisto-core GalNAcβ1-4Glc-
ceramide and to carry mainly terminal Lewis X trisaccharide units (165). Some of 
these glycolipids carry an additional fucose residue which is α1-3-linked to galactose 
thereby forming the so-called “pseudo-Lewis Y” motif Fucα1-3Galβ1-
4[Fucα3]GlcNAcβ- (165). The pseudo-Lewis Y motif has been, so far, neither 
detected in the adult nor in egg stages (165). Both glycan motifs are presented in 
Figure 6. In addition to the aforementioned glycolipids, cercariae express also 
glycolipids species that are highly antigenic and share antigenic motifs with the large 
glycolipids of the egg stage (160; 162). The role of Lewis X for the immune response 
to and the survival of the parasite is described in paragraph 1.3.4. 
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Figure 6. The Lewis X and pseudo-Lewis Y  motifs.  
Graphic representation of sugar  moieties as in Table 1. 
 
Size, complexity and antigenicity are increased in the egg glycolipids, being 
characterized by a backbone of N-acetylhexosamine residues decorated with 
oligofucosyl side chains, like Fucα1-3GalNAcβ1-4[±Fucα1-2±Fucα1-2Fucα1-
3]GlcNAcβ-. Analyses of egg glycosphingolipids demonstrated the preponderant 
presence of the repeating unit -4(Fucα1-2Fucα1-3)GlcNAcβ1- terminating in the 
case of S. mansoni in (Fucα1-2)0/1Fucα1-3GalNAcβ1- at the non-reducing end. In 
this context a panel of distinct carbohydrate epitopes can be defined: GalNAcβ1-
4GlcNAc- (LDN), Fucα1-3GalNAcβ1-4GlcNAc (F-LDN), GalNAcβ1-4(Fucα1-
3)GlcNAc (LDN-F), Fucα1-3GalNAcβ1-4(Fucα1-3)GlcNAc (F-LDN-F) and 
GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc (LDN-DF) (cf. Table 1). The major antigenic 
determinant found in egg glycosphingolipids was Fucα1-3GalNAcβ- as recognized 
by the monoclonal antibody (mAb) M2D3H (167). S. mansoni egg glycolipids 
exhibit strong biological activities as they were shown to induce cytokine production, 
thus leading to elevated interleukin-10 (IL-10), interleukin-6 (IL-6) and tumor 
necrosis factor alpha (TNF α) levels (146). 
Stage-specific expression pattern have not only been described for the glycan 
elements, but also for the ceramide part of schistosome mono- or dihexosides (164). 
In addition, the structural basis for the serological cross-reactivity between 
schistosome infection sera, schistosome glycolipid glycans and keyhole limpet 
hemocyanine (KLH) can be explained in terms of the N-linked glycan epitope 
Fucα1-3GalNAcβ1-4[Fucα1-3]GlcNAcβ-, i.e., F-LDN-F (55; 56). This cross- 
reactivity might be of biological relevance, as hemolymph glycoproteins of the 
S. mansoni intermediate host, Biomphalaria glabrata, also show cross-reactivity with 
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parasite glycoproteins and glycolipids (33; 89; 163). This sharing of carbohydrate 
motifs between parasite and host could be interpreted as an attempt of the parasite to 
camouflage itself and fits into the concept of “molecular mimicry” (25).  
1.3.4 The Lewis X motif in host-parasite relationship 
A number of recent studies have indicated a major role for Lewis X-containing 
glycoconjugates in the interaction of host and parasite. In this context, the most 
striking feature of this carbohydrate epitope is its shared occurrence in both the 
parasite and its host, as Lewis X is expressed in a wide range of human tissue (47) 
including glycolipids and glycoproteins of human granulocytes (49; 127; 132). 
Secondly, the temporal and spatial expression of Lewis X in schistosomes is of high 
interest. It has been observed that the cercariae express Lewis X only around gland 
openings (153), whereas this expression pattern changes completely when the 
parasite enters the mammalian host. During the transformation from cercariae to 
schistosomula the highly antigenic glycocalyx is stripped off, the tail is lost, the 
Lewis X epitope can be now multiply detected and on the entire, newly-formed 
surface of the schistosomulum by monoclonal antibodies (83; 85; 153). After 
developing to adult worms Lewis X remains to be constantly exposed at the site of 
parasite/host interaction, but is weakly expressed in the parasitic tegument. On the 
other hand, Lewis X-containing gut antigens like CCA are constantly secreted. 
Likewise, the shell of schistosomal eggs is decorated with Lewis X motifs, thus 
verifying again the continuous expression of Lewis X by the parasite (153). It could 
be further demonstrated that the Lewis X epitope is a target of the host´s immune 
response in schistosomiasis causing autoimmunity (107; 108). These auto-anti-
Lewis X antibodies have been shown to induce complement-dependent cytolysis of 
Lewis X-presenting host cells (108; 141). Furthermore, glycoconjugates carrying 
Lewis X moieties have an immunomodulatory effect as could be demonstrated by the 
induction of secretion of interleukin-10 in vitro (155; 156). Finally, which is a main 
topic of this thesis, parasitic Lewis X units can also target the innate immune system 
through binding to the C-type lectins, such as DC-SIGN, and might thereby be 
involved in the early cellular immune reaction to schistosomula. 
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1.4 Immune response to schistosomes 
 
During infection with schistosomes and most other helminths, the dominant immune 
response can be classified as Th2-like (95). Simplistically, Th responses can be 
considered to diverse into those dominated by IFN-γ producing Th1 cells, or 
IL-4/IL-5/IL-13-producing Th2 cells. Two main clinical conditions are distinguished 
during schistosome infection: acute and chronic schistosomiasis. 
1.4.1 Acute schistosomiasis- a Th1 response 
During acute illness, i.e., during the first 6 to 8 weeks post infection before eggs are 
deposited, often unspecific syndromes like fever occur (“Katayama syndrome”). 
When the parasite enters the host, prostaglandin D2 (PGD2), produced by the skin 
stage of S. mansoni, inhibits the migration of Langerhans cells to the draining lymph 
nodes, thereby delaying the immune response (4). These first weeks of infection 
represent a classical T helper 1 (Th1) type of response which is characterized by an 
increase of measurable levels of tumor-necrosis factor (TNF) in the plasma. In 
addition, peripheral-blood mononuclear cells (PBMCs) produce large amounts of 
IL-1 and IL-6 (27). The early phase of schistosome infection is less well investigated, 
but several mechanisms of immune regulation during the migration of schistosome 
have been described so far and are summarized in Figure 7.  
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Figure 7. Schematic diagram showing the possible mechanisms of immune 
regulation during the acute phase of schistosome infection whilst the parasite 
migrates through the human skin (modified after (70)).  
 
The abbreviations used are: APC, antigen-presenting cell; CLRs, C-type lectin 
receptors; DCs, dendritic cells; IL, interleukin; IL-1ra, interleukin-1 receptor 
antagonist; PAMPs, pathogen-associated molecular patterns; PGD2, prostaglandin D2; 
PGE2, prostaglandin E2; PRRs, pattern recognition receptors; sdLN, skin-draining 
lymph node lymphocyte; SMAF, S. mansoni apoptosis factor; TLRs, Toll-like 
receptors; TNFα, tumor necrosis factor alpha. 
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1.4.2 Chronic schistosomiasis - a Th2 response 
During infection with schistosome species, a chronic disease is the result of the 
ongoing host response to accumulating eggs trapped in the tissue. In the progression 
of the disease the egg-driven, developing Th2 response down regulates the 
production of the aforementioned pro-inflammatory cytokines. The switch from a 
Th1 to a Th2 response at the point of egg deposition is illustrated in Figure 8.  
 
Figure 8. Schistosome eggs induce a switch in the immune response from Th1 to 
Th2 (modified after (35)).  
The intensity of immune response during the time post infection is depicted for Th1 
cells (orange line), Th2 cells (blue line) and regulatory T-cells (T reg, black line). After 
infection with schistosomes the first immune response is a Th1 cell response. As the 
worms develop and egg production starts, natural killer (NKT) cells are activated, 
dendritic cells produce more IL-10 and less IL-12, and a Th2 cell response develops. In 
addition, B cells produce IL-10 in response to egg-derived antigens. Furthermore, 
populations of alternatively activated macrophages and regulatory T-cells are formed. 
IFN-γ interferon-γ; NO nitric oxide; TGF-β transforming growth factor beta; TNF 
tumor necrosis factor. 
 
In S. mansoni infection the liver is the mainly affected organ. As the sinusoids of the 
liver are too small for the eggs, they get stuck and die in the liver tissue. The CD4+ 
T-cell response that is induced by the trapped eggs orchestrates the development of a 
strong granuloma formation, composed of collagen fibers, macrophages and 
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eosinophiles, thus causing severe hepatosplenomegaly and increased liver portal 
blood pressure, as the liver becomes increasingly fibrotic. The main Th2 cytokine 
responsible for liver fibrosis is IL-13 (21). The fibrotic role of IL-13, together with 
IL-4, seems to be based on its ability to induce the expression of arginase in 
macrophages (64). Mediators that are associated with a Th1 response, like IFN-γ, 
IL-12, TNF or NO can prevent the IL-13 mediated fibrosis in mice (64). But IL-13 
itself is obviously not necessary for the Th2 development per se (41). 
S. mansoni egg-induced granuloma formation and the composition of a granuloma in 
the liver are outlined in Figure 9. 
 
 
Figure 9. Formation of liver granuloma due to dieing parasitic eggs (modified after 
(117)).  
The CD4+ T-cell response that is induced by trapped eggs, mainly in the liver, leads to the 
development of granulomatous lesions. Granulomes are composed of collagen fibers and 
different cell types, including macrophages, eosinophiles and CD4+ T-cells.  
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Several cytokines other than IL-4 have been implicated in the Th2 development, but 
have been found to be of minimal importance for the expression of this type of 
immune response (117). IL-6, for example, does not play a main role during Th2 
phase, although it might be involved at some level in the regulation of IFN-γ and 
IL-12 production (87). 
The function of B cells during schistosomiasis is still under investigation. One study 
showed that effector B cells can induce a Th2 response through the production of 
polarizing cytokines (61). The finding that CD40-CD154 interactions are important 
for the development of a Th2 type of response during schistosome infection also 
implicates that B cells might be involved in this process, since B cell responses are 
markedly impaired in the absence of CD40 signaling (100; 149). In addition, it has 
been demonstrated that CD40-/- DCs are incapable of inducing egg-antigen-specific 
Th2 responses (97). 
Several studies underline that it is the egg stage of the schistosome that is responsible 
for the induction of a Th2 response (57; 116). In contrast, the worms themselves 
seem to be poor inducers of a Th2 answer. The Th2 phase is characterized by 
increased numbers of eosinophiles, basophiles and mast cells as well as high levels 
of circulating IgE. Hence, schistosomes, as well as, other parasitic helminths 
inducing Th2 responses, may be used as model organisms for studying the 
development and function of this type of immune response.  
The induction of a Th2 response by schistosomes is summarized in Figure 10. 
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Figure 10. Induction of a Th2 response (modified after (117)).  
S. mansoni alive helminths and excreted/secreted antigens modify cells of the innate 
immune system by interaction with TLRs and CLRs to stop the production of 
inflammatory mediators and to elicit the output of immunoregulatory cytokines like 
IL-10. This results in the generation of suppressive regulatory T-cells (Treg) and a shift 
towards a Th2 response. Abbreviations used are: aaMФ, alternatively activated 
macrophage; B7-1/B7-2, protein on the surface of antigen-presenting cells (2nd signal); 
CD, cluster of differentiation; CLR, C-type lectin receptor; CD40L, CD40 ligand; 
CTLA-4, cytotoxic T-lymphocyte antigen 4; DC, dendritic cell; MHC, major 
histocompatibility complex; NKT, natural killer cell; NFκB, nuclear factor kappa B; 
NO, nitric oxide; S. mansoni Ags, S. mansoni antigens; TCR, T-cell receptor; TLR, 
Toll-like receptor.  
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1.5 Immunevasion of the pathogen 
 
At least three early findings arouse the interest of immunologists in schistosomiasis: 
the immune response is clearly involved in the development of many of the 
pathological changes accompanying infection, the patients can exhibit resistance to 
superinfection, and schistosomes may survive for years in the host despite a strong 
immune response (117). To this end parasites have evolved an intricate series of 
adaptations enabling them to survive for decades in the host without causing host 
mortality. They manage to escape or suppress the immune response while and 
simultaneously avoid overwhelming their hosts. In this context, schistosomes have 
developed an impressive array of immune evasion mechanisms including the ability 
to coat themselves with host antigens (molecular mimicry), to enzymatically cleave 
antibodies and to rapidly release distinct surface layers with unique double 
membranes, using pre-formed membrane vesicles (118). Apart from employing 
immune evasion strategies, schistosomes also subvert and thereby utilize the host’s 
immune response to facilitate their own development and transmission. The 
production of eggs by female worms is, for example, dependent on host-derived TNF 
(3). Adult worms may also use host-derived TGF-β as a regulator of their own 
growth (10). Furthermore, schistosomes are adapted to and might promote genetic 
changes in both the intermediate and the definitive human host. So far, only in snails 
evidence for this conclusion is provided by the fact that snail strains can be selected 
dependent on their susceptibility towards schistosomal infection (158).  
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1.6 Glycans and their role in schistosomiasis 
 
A wide range of both parasite- and host-derived glycoconjugates have been 
investigated for their role in the induction of a Th2 response by schistosomes in order 
to correlate defined carbohydrate structures with their biological properties in 
schistosome immunology.  
Glycosylated components of schistosomal eggs have been shown to affect the 
production of cytokines by DCs (171). Furthermore, DCs stimulated by egg-derived 
antigens in vitro are able to promote a Th2 cell response in vivo (96). Egg 
glycoproteins can also bind to macrophage mannose receptor (63). Recent studies 
have shown that carbohydrates off egg antigens are of integral importance for the 
induction of a Th2 response. Likewise, related model compounds like Lacto-N-
Fucopentaose III (LNFP, containing the Lewis X motif) induce a strong Th2 
response (113), whereas the non-fucosylated form lacks this ability. It could be 
further demonstrated that the activation of TLR4 via LNFP III leads to an activation 
of the ERK (Extracellular-signal regulated kinase) pathway only, whereas after 
LPS-induced stimulation 3 different pathways (ERK, P23, JNK) are addressed (138).  
Natural killer T (NKT) cells are similarly activated and stimulated by glycolipids of 
eggs and adult worms (171). NKT-cells as well as eosinophiles and mast cells are 
potent sources of IL-4; however, the absence of these cell types does not prevent the 
establishment of Th2 cell responses in infected mice (15; 119). It could be 
demonstrated that schistosome-specific phosphatidylserine activates TLR2 at the cell 
surface of DCs. This results in mature DCs (mDCs) with the capacity to promote the 
development of IL-10 secreting regulatory T-cells (Tregs) (145). Tregs induced by 
helminths have the potential to suppress the Th1 cell response to helminths-derived 
antigens, thereby ensuring Th2 cell polarization (102). The described induction of 
Tregs seems to be an essential control mechanism preventing an over-vigorous 
immune response during chronic infection.  
One of the most fascinating features in parasite immunology is how the host detects 
the pathogen and gets rid of the invader without destroying self-antigens/-tissues. 
Recent work underlines that glycoconjugates, that are expressed through all life-
cycle stages of the parasite, play an important role in the escape mechanisms of the 
pathogen. The first cells that come into contact with invading schistosomula are 
dendritic cells. They recognize pathogens and, via interaction with T-cells, an 
immune response is activated. The emerging role of carbohydrates in the 
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immunology of schistosomiasis opens up the possibility that innate patter-recognition 
receptors, that recognize parasitic glycans, may have a crucial role in the induction of 
a Th2 response. In the next paragraph pattern recognition receptors, dendritic cells 
and their role in immune responses to schistosomes will be discussed. 
 
1.7 Dendritic cells 
 
Beside macrophages, dendritic cells (DCs) are the major antigen presenting cells 
(APCs). In 1868 Paul Langerhans observed a subpopulation of DCs - the so-called 
Langerhans cells- in the skin, but he misclassified them as nerve cells (88). It took 
more than 100 years until the function of dendritic cells could be defined, in more 
detail, as Ralph Steinman and Zanvil Cohn reported in 1973 a new cell type in 
murine lymphoid organs, which they named dendritic cells in accordance to their 
tree-like cytoplasmic extensions (131). DCs represent a special type of leukocytes 
which is able to alert the immune system to the presence of infectious agents and is 
responsible for activation and control of both innate and adaptive immune responses. 
DCs are especially distributed in tissues that interface the external environment like 
the skin, the gut and the lungs. DCs have a unique capacity to sample sites of 
pathogen entry, respond to pathogenic signals and potently activate naïve T-cells to 
proliferate and differentiate into Th1, Th2 or Treg cells. Three signals are necessarily 
delivered by APCs to determine the fate of the naïve T-cells (106). Signal 1 is 
induced by the T-cell receptor (TCR), when binding an appropriate peptide-MHC 
complex. Signal 1 alone is thought to promote naïve T-cells into anergy or deletion, 
thereby promoting tolerance. Co-stimulatory signals in combination with signal 1 
induce immunity, mirrored in T-cell clonal expansion and differentiation into 
effector cells. Signal 2 is the co-stimulatory signal mediated by triggering of CD28 
by CD80 and CD86. Signal 3 is the polarizing signal mediated by soluble or 
membrane bound factors like IL-12 (Th1) or CC-chemokine ligand 2 (CCL2) (Th2) 
(72). 
Following antigen uptake, DCs efficiently process antigens for their presentation in 
association with major histocompatibility complex (MHC) molecules. As a 
prerequisite for being able to prime the adaptive immune response, however, DCs 
have to mature. Maturation of DCs is characterized by a decreased antigen-uptake 
capacity and an increased cell surface expression of MHC and co-stimulatory 
molecules (8; 19). In addition, rearrangements of cytoskeleton, adhesion molecules 
Introduction 23
and cytokine receptors occur during maturation and allow DCs to migrate from 
peripheral tissues to secondary lymphoid organs (120).  
In summary, the interaction with pathogens results in activated DCs which migrate to 
the T-cell area of the lymph nodes, where antigen-specific cells of the adaptive 
immune response can be primed. Therefore dendritic cells are often called “sensors 
of the immune system“.  
Interest in the function of DCs during schistosomiasis was strongly increased, when 
MacDonald and coworkers discovered that DCs pulsed in vitro with SEA induced a 
SEA-specific Th2 response, when reinjected in mice (96). Furthermore, SEA could 
condition human DCs to polarize Th responses in a Th2 direction in vitro (28).  
The adaptive immune response to a pathogen develops after the initiation of innate 
immune reactions that requires the recognition of pathogenic antigens. Pathogen-
expressed molecules that stimulate the innate immune response are termed pathogen-
associated molecular patterns (PAMPs). Prominent examples are lipopolysaccharid 
(LPS) of gram-negative bacteria and peptidoglycans of gram-positive bacteria, as 
well as polysaccharides of fungal cell walls (136). The recognition of PAMPs is 
mediated by pattern-recognition receptors (PRRs) that consist of the large families of 
toll-like receptors (TLRs) and C-type lectins (CLRs).  
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1.8 C-type lectins 
 
Recognition of carbohydrates is mediated by a specialized family of host receptors, 
named lectins, which bind glycans via one or more so- called carbohydrate 
recognition domains (CRDs). There are different classes of animal lectins, such as 
siglecs, galectins or the C-type lectin receptors (CLRs), which can be distinguished, 
on the basis of conserved regions in their amino acid sequence. The CLRs bind 
carbohydrates in a calcium-dependent manner, and the Ca2+-ions are directly 
involved in the binding of the ligand as well as in maintaining the structural integrity 
of the lectin. The high affinity binding of some lectins is achieved through high 
avidity by multivalency of the ligand, by multiple CRDs within one lectin or via 
clustering of lectins containing one single CRD. The C-type lectins comprise a 
prototypic lectin fold, consisting of two anti-parallel β-strands and two α-Helices 
(159). The CLRs are either transmembrane proteins or secreted as soluble proteins, 
like members of the collectins family and the mannose-binding protein (MBP) (76; 
93). The transmembrane CLRs are divided into two subfamilies, type I or type II C-
type lectins depending on their N-terminus pointing outwards or inwards the 
cytoplasm. Examples of transmembrane C-type lectins are the selectins, the mannose 
receptor (MMR) family and DC-SIGN (37; 53; 90). A summary of type I and type II 
C-type lectins that are present on dendritic cells or Langerhans cells is given in 
Figure 11. 
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Figure 11. Classification of C-type lectins (modified after (45)).  
Type I C-type lectins (MMR and DEC-205) contain an aminoterminal cysteine rich 
repeat, a fibronectin type II repeat and 8 to 10 carbohydrate recognition domains 
(CRD). Type II C-type lectins contain only one CRD at their carboxyterminal 
extracellular domain.  
 
Despite the fact that several CLRs share a common CRD the different assembly 
architecture and spacing of these domains create unique sets of carbohydrate 
recognition profiles for each receptor. A good example is the different recognition of 
Lewis blood-group antigens by completely different CLRs. While DC-SIGN 
recognizes unsialylated Lewis X and Lewis A units, P- and E-selectin express high 
affinity towards sialylated Lewis X and Lewis A moieties (5; 48).  
The main function of CLRs is the binding and subsequent internalization of antigens 
for direct elimination by macrophages. At the same time lysosomal degradation 
produces antigenic fragments which stimulate the adaptive immune system after their 
presentation by DCs and macrophages via MHC molecules at the cell surface (45).  
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1.8.1 DC-SIGN 
The dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin 
(DC-SIGN, CD209) was first characterized as a receptor interacting with 
intercellular adhesion molecule 3 (ICAM-3) (53). It was subsequently shown to bind 
also ICAM-2 on vascular endothelial cells, thereby regulating DC migration (51). 
Both of these interactions are mediated by N-linked high-mannose structures 
(typically consisting of 5-9 mannose units). Mannose-dependent recognition 
processes are also responsible for the interaction of DC-SIGN with different 
pathogens. DC-SIGN was primarily described as HIV-1 receptor that enhances 
infection of T lymphocytes in trans (52). Ever since, increasing evidence has been 
accumulated that, besides HIV, a multitude of pathogens uses DC-SIGN as entry 
gate, as already described for severe acute respiratory syndrome coronavirus (SARS) 
(168), filoviruses (101), Hepatitis C virus (94), the fungus Candida albicans (17) as 
well as the bacterium Mycobacterium tuberculosis (133). Biochemical studies have 
shown that a significant proportion of DC-SIGN is located in detergent-resistant 
membrane fractions, where lipid rafts can also be found. However, disruption of lipid 
rafts by cholesterol extraction did not change the integrity of DC-SIGN 
microdomains, suggesting the existence of additional molecular determinants 
regulating the association of transmembrane protein, like DC-SIGN, with lipid rafts 
(16). Nevertheless, the localization of DC-SIGN in these lipid microdomains may 
create a scaffold that favors pathogen binding and may simultaneously allow the 
interplay of DC-SIGN with signaling molecules that are located in the same 
membrane domains.  
As outlined above, DC-SIGN is a type II membrane C-type lectin with a short N-
terminal cytoplasmic tail and a single C-terminal CRD (53). This CRD recognizes 
equally well internal branched mannose units as well as terminal di-mannosyl motifs 
(44; 105). In addition, DC-SIGN binds fucosylated epitopes, preferentially α1-3 
and/or α1-4 fucosylated tri- or tetrasaccharides including Lewis antigens and LDNF 
(5; 148). The cytoplasmic tail contains three internalization motifs, as one main role 
of C-type lectins is to internalize pathogen specific antigens for processing and 
antigen presentation, thereby inducing the specific immune response (150). The 
internalization motifs of DC-SIGN are composed of a di-leucine motif, a tyrosine-
based motif with the sequence YKSL, and a triacidic amino acid cluster EEE, the 
first two of which are involved in antigen internalization (40). A schematic structure 
of DC-SIGN is given in Figure 12. 
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Figure 12. Schematic overview of the structure of DC-SIGN (modified after 
(150)).  
One of the two Ca2+ is shown and interacts with four amino acids (Glu347, Asn349, 
Glu354, Asn365). Val351 has been shown to be involved in the recognition of some 
ligands. The CRD (red) of DC-SIGN is separated from the transmembrane (TM, green) 
region by a neck domain that consists of seven complete and one incomplete tandem 
repeats (light blue). The cytoplasmic tail (dark blue) contains internalization motifs 
such as the di-leucine (LL) motif and the tri-acidic (EEE) cluster and an incomplete 
immunoreceptor tyrosine (Y)-based activation motif (ITAM). 
 
DC-SIGN delivers antigens to intracellular vesicles, which are comparable with late 
endosomes/lysosomes. As shown for HCV, resulting antigen fragments are 
subsequently presented to T-cells in vitro (40; 94). Some pathogens, however, may 
selectively use the method of DC-SIGN-mediated antigen uptake to escape from the 
host’s immune defence (150).  
DC-SIGN interacts with S. mansoni SEA. Using anti-glycan antibodies it could be 
demonstrated that this binding is mediated by high-mannose type glycans as well as 
Lewis X and LDNF motifs (148). Glycan array studies verified that DC-SIGN 
recognizes besides glycans with terminal Manα1-2Man units also fucosylated 
glycans with Fucα1-3GlcNAc and Fucα1-4GlcNAc moieties (58). 
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In chapter 2 of this thesis we demonstrate that DC-SIGN interacts not only with the 
Lewis X motif present in cercarial glycolipids, but also with the pseudo-Lewis Y 
epitope, thus representing the first parasite-specific ligand for DC-SIGN. 
1.8.2 L-SIGN 
Liver/lymph node specific ICAM-3-grabbing nonintegrin (L-SIGN, CD209L, 
DC-SIGN-R) is a homologue of DC-SIGN (9; 123). L-SIGN shares 77% amino acid 
sequence identity with DC-SIGN. L-SIGN is not expressed on human dendritic cells, 
but occurs on liver sinusoidal endothelial cells (LSECs) (9). These liver-resident 
cells function as antigen presenting cells and may therefore have the capacity for 
antigen clearance (81). Moreover, L-SIGN mediates LSEC-leukocyte adhesion (82).  
The crystal structures of the CRDs of L-SIGN and DC-SIGN revealed that both 
receptors recognize high-mannose type glycans (44; 105). Additional binding studies 
demonstrated that L-SIGN has a higher affinity for mannose than DC-SIGN (58). 
L-SIGN is able to bind to ICAM-2 and ICAM-3 similar to DC-SIGN and may 
establish cellular interactions with ICAM-3 expressing T-cells (9). Furthermore, both 
C-type lectins recognize carbohydrate structures on pathogens, such as ManLAM of 
M. tuberculosis and high-mannose type glycan moieties of viruses like HIV-1, HCV 
and Ebola (84). The question as to whether L-SIGN is also able to incorporate 
antigens, is under current discussion. Ludwig et al. demonstrated that L-SIGN 
transfected cells internalize hepatitis C virus particles. The subsequent degradation of 
these particles, however, is prevented, since they escape into non-lysosomal vesicles 
(94). In contrast to these findings Guo and co-workers showed that L-SIGN 
expressed on fibroblasts did not release the ligand, even at low pH and did not 
mediate endocytosis, which underlines that L-SIGN functions more as adhesion than 
as internalization receptor (58). Nonetheless, L-SIGN displays considerable 
homology to DC-SIGN in the cytoplasmic tail and shares potential internalization 
motifs such as the triacidic cluster (EED) and the di-leucine motif, whereas the 
tyrosine based motif is lacking (84). The schematic structures of L-SIGN and 
DC-SIGN are displayed in Figure 13 for comparison. 
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Figure 13. Schematic overview of the structure of DC-SIGN and L-SIGN.  
DC-SIGN contains seven complete and one incomplete tandem repeats. The amount of 
repeats in L-SIGN is variable between three and nine (indicated with arrows). Within 
the cytoplasmic tails several internalization motifs are present, though L-SIGN lacks 
the tyrosine-based motif. 
  
As the di-leucine motif has been shown to be essential for internalization in the case 
of DC-SIGN (125), and as this motif is conserved in L-SIGN, it is still possible that 
L-SIGN might function as an internalization receptor as well. Like DC-SIGN, 
L-SIGN binds to several Lewis antigens, except Lewis X (151). It has been also 
described that L-SIGN binds soluble egg antigens (SEA) from S. mansoni (151). A 
further specification of the ligands involved in these binding processes is presented 
in the publication Meyer et al. (2007) in chapter 2 of this thesis. 
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1.9 Interaction of C-type lectins with other receptors 
 
In the past few years evidence has been accumulated illustrating the importance of 
CLRs for proper function of the immune system. From these data, a picture emerged 
suggesting that the recognition of pathogens is based on a complex network between 
CLRs and other recognition receptors of the innate immune system. One family of 
such receptors includes the so-called Toll-like receptors (TLRs) (134; 145). Besides 
CLRs, TLRs present, in particular, on DCs and macrophages are also involved in the 
direct recognition of specific PAMPs (134). While the main function of CLRs is to 
internalize antigens for degradation in order to enhance antigen processing and 
presentation (45), TLRs recognize foreign macromolecules and trigger intracellular 
signaling cascades, thus leading to the production of proinflammatory cytokines and 
T-cell activation (134). The interaction of TLRs and CLRs and their crosstalk is 
important for the balance between immune tolerance and immune activation. C-type 
lectin stimulation can either enhance or inhibit TLR signaling. This has been in detail 
described for Mycobacterium tuberculosis, showing that the binding of ManLAM to 
DC-SIGN inhibits the production of IL-12 and promotes the production of IL-10 
elicited by the TLR4 ligand Escherichia coli LPS. TLRs control the switch between 
tolerogenic and activating immune responses. Recently, TLR-2 and TLR-4 have also 
been shown to be recruited into lipid rafts (126; 139), which favors the 
communication between neighbored CLRs and TLRs. Hence, pathogen recognition 
is not the result of an interaction of one compound of a pathogen with a single 
receptor, but requires a complex network of interacting receptors and ligands. The 
outcome of this recognition can be totally different, depending on the type of 
receptors involved and their cellular localization. It can result in the clearance of the 
pathogen, but may also lead to a strong adaptive immune response or to the induction 
of tolerance.  
Studies on the effect of SEA on DCs revealed that SEA exhibits suppressive effects 
on the signaling initiated by classical inflammatory TLR ligands. Evidence for this 
assumption has been provided by co-pulsing DCs with SEA plus E. coli LPS or 
Toxoplasma gondii antigen (69; 171). In both cases, the activation by the 
inflammatory stimuli has been substantially inhibited by SEA. Pearce and coworkers 
reported, that this reduced responsiveness to TLR-ligands reflects, in part, the fact 
that SEA augments TLR ligand-induced production of IL-10 (73). However, 
analyses in IL-10-/- DCs revealed that distinct IL-10-indepedent mechanisms are 
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responsible for the suppressive effects of SEA. The question, how SEA is able to 
suppress TLR-initiated signaling, is the focus of ongoing research.  
Besides TLRs and C-type lectins, Galectin-3, a well characterized member of the 
galectin family, recognizing galactose and GalNAc epitopes via its C-terminal CRD 
has been similarly described to bind to schistosomal glycans (144). Recent data 
revealed that galectin-3 recognizes LDN epitopes containing terminal β-GalNAc 
residues and interacts with LDN units in SEA (144). In agreement with this finding, 
a co-localization of LDN motifs on the parasitic egg shell and galectin-3 during 
granuloma formation has been observed in liver granuloma of infected hamsters. As 
galectin-3 is synthesized and secreted by many cell types including dendritic cells, 
the interaction of C-type lectins and galectins is of high interest in view of the 
immunology of helminth infection.  
The collaborative recognition of, e.g., pathogen-derived glycoconjugates by different 
types of receptors is crucial for the regulation of an appropriate immune response to 
schistosome infection. As a prerequisite for further cell biological/immunological 
studies, however, detailed structural characterization of the ligands bound to the 
lectin has to be performed. Therefore different methods to define the precise 
carbohydrate recognition profile have to be applied. 
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1.10 Methods to study the interaction of lectins and ligands 
 
Therapeutic manipulation of carbohydrate-lectin interactions needs- not only in the 
case of parasitic infections- detailed knowledge of the specific set of carbohydrates 
being recognized by the lectin of interest. In recent years different methods have 
been established to facilitate a systematic and high-throughput analysis of protein-
carbohydrate interplay. In chapter 2 of this thesis a collaborative study with C.H. 
Grün is presented, describing the development of a simple and fast procedure for the 
biotinylation of carbohydrates based on reductive amination. The method allows 
complete and stable biotinylation of small quantities of oligosaccharides and includes 
a rapid and simple procedure to remove excess labeling reagent. Such glycan 
derivatives can be subsequently used for binding studies. Undoubtedly, however, the 
use of high-throughput glycan arrays is the method of choice to discriminate between 
high- and low affinity carbohydrate ligands. This technique could be successfully 
used in studies demonstrating that L-SIGN and DC-SIGN differ in their 
carbohydrate-binding profile (58). Release of the glycan moieties from parasitic 
glycolipids, purification of the glycan epitopes and subsequent attachment to a 
synthetic lipid-anchor was used as method of choice in the first manuscript presented 
in chapter 2 of this thesis (Meyer et al.; 2005; JBC). Formation of such 
neoglycolipids could be of general interest not only in the context of released 
glycolipid-glycans, but also with regard to carbohydrates originating from 
glycoproteins, proteoglycans and whole organs of the parasite. It could be, therefore, 
of great interest to combine the neoglycolipid technology with array techniques using 
different lectins. Two main drawbacks circumvent this goal currently: it is often 
almost impossible or at least very time-consuming to achieve parasitic material in the 
required amounts, and isolation of pure compounds to be used in arrays is usually 
very difficult. Therefore, the use of chemically synthesized oligosaccharides could be 
a promising strategy to test glycans with known parasitic glycan motifs in lectin 
binding studies. A further challenging but promising technique is X-ray 
crystallography which enables the analysis of covalent and non-covalent interactions 
in three dimensions, thus providing the basis for the understanding of binding of 
ligands to proteins. Drickamer and coworker were able to crystallize DC-SIGN and 
DC-SIGNR (= L-SIGN) together with different ligands (44). These crystal structures 
of the carbohydrate-recognition domains bound to the respective oligosaccharides, in 
combination with binding studies, revealed that these receptors selectively recognize 
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endogenous high-mannose type oligosaccharides. The same group was able to 
crystallize DC-SIGN together with the fucosylated ligand LNFP III showing the 
affinity of DC-SIGN to fucose-moieties (58). Besides crystallization and subsequent 
X-ray studies molecular modeling is a further strong technique to gain more insights 
in ligand-binding. Molecular modeling is a collective term that refers to theoretical 
methods and computational techniques to model or mimic the behavior of molecules. 
Thereby the interactions between neighboring atoms may be described and binding 
modes resulting in the lowest steric energetic state are calculated. A more molecular 
genetic tool is to induce mutations at specific positions in the CRD to investigate the 
role of different amino acids in ligand binding. Taken together, all these techniques 
will draw a clearer picture of ligand/lectin interactions. 
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2 Publications resulting from this work 
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3 Discussion 
 
In this chapter a synopsis of the obtained results will be presented together with an 
outlook on ongoing and future work.  
In this thesis we have been interested in the question as to how human cells 
recognize an invading parasite, a process that involves both signature molecules of 
the pathogen and specific receptors on the host cell. Therefore, we investigated how 
specific glycoconjugates of the parasite S. mansoni are recognized by the two C-type 
lectins DC-SIGN and L-SIGN. The first publication resulting from this thesis 
describes the binding of authentic cercarial glycolipids from S. mansoni to the C-type 
lectin DC-SIGN. It could be further demonstrated that this interaction is mediated by 
Lewis X and pseudo-Lewis Y carbohydrate motifs. These epitopes are also present in 
the glycolipids of excretory/secretory (ES) products released from cercariae (104). In 
a second publication, the binding specificity of L-SIGN was investigated, 
demonstrating that this C-type lectin recognizes high-mannose type N-glycans of 
SEA as well as fucosylated glycolipids of schistosome eggs (103). The third 
publication reports on a new method allowing a rapid biotinylation of carbohydrates 
to simplify their usage for ligand/lectin studies which is applicable not only for 
parasitic ligands. 
 
The early phase of schistosome infection and the concomitant role of carbohydrates 
The parasite S. mansoni has evolved different strategies to survive in its hosts by 
down-regulating the immune response to benefit its own survival (117). In this 
context, the eggs are the main inducers of the shift from an early Th1 to a strong Th2 
response (57). Notwithstanding the egg-induced immune modulation, there is an 
increasing number of reports claiming that immune regulation begins before egg 
deposition already in the cercarial stage (70). The role of carbohydrates in this 
process has been further established in the last years (65; 147). Likewise, studies on 
the function of lectins recognizing host-like or parasite-specific glycans in the 
immune processes of schistosome infection have gained increasing importance. 
However, before analyzing the different signaling pathways involved, the precise 
structures of the glycan-epitopes bound by the C-type lectins need to be elucidated. 
We could demonstrate that DC-SIGN recognizes authentic cercarial glycolipids 
carrying the Lewis X or the pseudo-Lewis Y epitope. Our observation, that in 
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contrast to cercarial glycolipids, egg glycolipids interacted only poorly with 
DC-SIGN is in agreement with previous studies, showing that the pseudo-Lewis Y 
epitope is solely found in cercarial glycosphingolipids, and Lewis X containing 
glycosphingolipids represent only a very small fraction of total egg stage 
glycosphingolipids (104; 165). In addition to Lewis X and pseudo-Lewis Y epitopes 
expressed on cercarial glycolipids (104), DC-SIGN also recognizes Lewis X and 
LDN-F motifs as well as high-mannose type glycans of schistosomal egg 
glycoproteins (148; 151). To understand how different glycan antigens can interact 
with DC-SIGN, the binding mode was determined by molecular modeling based on 
the crystal structure of DC-SIGN complexed with a Lewis X oligosaccharide. 
Interestingly the binding domain of DC-SIGN seems to be flexible due to the ability 
of the Phe313 side-chain to change its orientation, thus allowing an interaction with 
both Lewis X trisaccharide and pseudo-Lewis Y tetrasaccharide. It has been reported 
earlier that the binding pocket of a lectin may change depending on the structural 
features of the glycan bound (75; 105). Possibly pathogens such as S. mansoni may 
use this flexibility to target DC-SIGN.  
 
Excretory/secretory products from cercariae 
Schistosomes invade humans in the cercarial stage, and these cercariae transform 
into schistosomula directly after penetration of the skin by shedding their glycocalyx 
and releasing ES products. The latter compounds are rich in components of the 
highly glycosylated glycocalyx and products from the acetabular gland, containing 
serine proteases (70). Said ES products enter the surrounding human tissue and may 
be encountered by surveying DCs, such as the DC-SIGN positive CD1a negative 
dermal DCs, which are found mostly in the upper dermis (39; 53; 124). The 
immunomodulatory effect of these ES products has long been realized, but still little 
is known about the specific glycans leading to an immune response to ES products 
(91). Analyses performed in this thesis revealed that glycolipids present in these ES 
products contain species with Lewis X and pseudo- Le Y determinants (104). In 
contrast to Lewis X, which is found in both mammals and several pathogens, 
pseudo-Lewis Y is so far only described for schistosomes. Hence, is this 
pseudo-Lewis Y motif is the first parasite-specific ligand described for DC-SIGN. 
These results may enable follow-up studies to further investigate the role of the 
interaction between DC-SIGN and schistosomal glycolipids in host immunity. The 
schistosomula-released antigens stimulate not only innate immune cells, but are also 
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effective in limiting strong host immune responses. It is proposed that the active 
shedding of surface antigens may serve as an important source of parasite antigens 
available to the immune system in a form in which they can be taken up and 
processed by antigen-presenting dendritic cells, macrophages and certain B cells for 
presentation to T helper cells (91). Vieira et al. reported, that material released from 
cercariae could inhibit the in vitro proliferation of human PBMCs from schistosome 
infected patients in response to adult worm antigens (157). Moreover, several studies 
have shown that cercarial ES products, lead to the formation of edema and influx of 
neutrophiles when they are used to stimulate naïve skin (42; 137). Taken together 
these results led to the suggestion that products released by cercariae have the ability 
to modulate the host’s immune response and promote the survival of the parasite. 
DC-SIGN recognizes cercarial glycolipids, but other molecules may be additionally 
involved.  
 
Glycolipid signaling 
Studies on the presentation of glycolipids to DCs have not been performed yet. Since 
it is unlikely that such a complex mixture of secreted glycoconjugates is recognized 
only by one lectin, a complex pattern of receptors on dendritic cells may be involved 
in antigen presentation. The role of glycolipids in signaling is still poorly understood. 
Faveeuw et al. have shown, however, that compounds of SEA are presented on 
CD1d which is also involved in glycolipid presentation for other pathogens (43). The 
antigen presentation of parasitic glycoconjugates to Cd1d-expressing T cells may be 
important for the induction of a Th2 response and the egg-induced pathology of 
schistosome infection. As DC-SIGN recognizes cercarial glycolipids carrying 
Lewis X or pseudo-Lewis Y motifs, it would be of high interest to investigate, as to 
whether these glycolipids are also presented to CD1d molecules. As pseudo-Lewis Y 
is a parasite-specific epitope, it could play a prominent role in the induction of an 
immune response to schistosomes. 
 
The Th1 to Th2 switch and the role of DCs 
It is known that schistosomes switch the immune response from a primarily Th1 to a 
strong Th2 response in the moment of egg deposition. The molecular mechanisms by 
which eggs or their secreted products induce a Th2 answer are not clear. In this 
context, a key role has been suggested for both human and murine dendritic cells, 
since DCs pulsed with SEA are able to elicit a Th2 response (96). But the response of 
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murine DCs to SEA led to surprising results, as they failed to up-regulate MHC II 
and co-stimulatory molecules. Moreover, murine SEA-pulsed DCs did not produce 
cytokines, whereas human DCs pulsed with SEA were described to fail in 
conventional maturation (152), but they are able to induce a Th2 response. These 
findings may lead to the suggestion that, besides DC activation, other DC-linked 
mechanisms may play a role in Th2 priming. We are currently testing, in cooperation 
with the group of Irma van Die and Yvette van Kooyk, whether DCs stimulated with 
schistosomal glycolipids are able to induce a Th2 response in naïve T cells. 
Preliminary results have shown that the induction of a Th2 response by schistosome 
glycolipids seems to be fucose-dependent, as a shift to Th2 was not observed with 
defucosylated HF-treated glycolipids. 
 
The cytokine profile induced by schistosomes 
The tendency of DCs to promote Th2 response, after being stimulated with helminth 
products, may reflect their inability to produce Th1-promoting cytokines like IL-12; 
IL-23 and IL-27 (115). In this respect it has been already shown that neither SEA nor 
products released by larvae 0-3 hours after transformation (0-3 hRP) are able to 
induce IL-12p70 production (71). Furthermore, 0-3 hRP inhibits the IL12-p40 
release by macrophages when co-stimulated with LPS or Zymosan A, normally 
strong IL-12 and thereby Th1 inducers (70). In the same studies, however, levels of 
IL-6 and IL-10 were increased. In the case of DCs, the stimulation with 0-3 hRP 
expanded the amount of IL-12 in response to CD154-transfected fibroblasts (71). 
This indicates that 0-3 hRP has different effects on DCs and macrophages, maybe 
due to the expression of different surface receptors. As we are already analyzing the 
response of DCs to schistosomal glycolipids, it would be of further interest to 
investigate, how macrophages respond to schistosomal glycolipids. 
 
The role of TLRs in schistosome infection 
The role of Toll-like receptors (TLRs) during schistosome infection represents 
currently a broad field of interest. The group of Francois Trottein analyzed distinct 
TLR members with regard to their ability to respond to living schistosome eggs, 
demonstrating for example that double-stranded RNA (dsRNA) from schistosome 
eggs is able to activate TLR3 resulting in the activation of NF-kappa B. In addition 
they showed that stimulation of DCs with schistosome eggs results in type I 
interferon (IFN) and IFN-stimulated gene (ISG) expression. Furthermore, S. mansoni 
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eggs were shown to activate myeloid differentiation factor 88 (MyD88)-dependent 
and MyD88-independent pathways in DCs (2). The Lewis X epitope, present in 
Lacto-N-fucopentaose III (LNFP III), can directly activate murine bone 
marrow-derived DCs by a TLR 4-dependent mechanism. Lewis X functions as an 
innate Th2 promoter via its action on murine dendritic cells, and it has been 
demonstrated that the α1-3-linked fucose constituent is required for this activity 
(138). Lyso-phosphatidyl-serine (lyso-PS), isolated from S. mansoni eggs, was 
shown to activate human monocyte-derived DCs through TLR 2, thus leading to the 
development of IL-10 producing regulatory T cells and the induction of a Th2 
response (145). In some publications lyso-PS is called glycolipid (2; 22), which is 
wrong. Until now no investigation of the interaction on glycolipids from 
schistosomes and TLRs has been published.  
 
Other CLRs involved during schistosomiasis 
Besides TLRs and the CLRs, DC-SIGN and L-SIGN, mentioned above 
schistosome-derived glycans can be recognized by further CLRs present on DCs. 
The macrophage galactose-type lectin (MGL), for example, binds to LDN and LDN-
F moieties of SEA (154). For the mannose receptor (MR) the specific glycans 
mediating binding to SEA have not yet been identified, but they may also be 
assumed mannose-containing epitopes (92).  
 
The signaling of CLRs 
CLRs contain signaling motives in their cytoplasmic domains which might be able to 
activate intracellular signaling cascades after ligand binding (45). This field of 
research has to be further investigated, but for some signaling motifs their general 
function has already been elucidated. DC-SIGN contains a tyrosine-based motif 
which is involved in the rapid internalization of ligands from the cell surface (13). 
Both DC-SIGN and L-SIGN possess a di-leucine motif in their cytoplasmic tail 
which is responsible for the targeting to lysosomal/endosomal vesicles and is also 
involved in receptor-mediated endocytosis (99). In addition DC-SIGN and L-SIGN 
comprise a tri-acidic cluster which plays a role in the transport to MHC II-positive, 
late endosomes and lysosomes (14). The occurrence of these signaling motifs 
explains the targeting of SEA to MHC II-positive, lysosomal compartments (152). 
Hence SEA captured by C-type lectins might be presented on MHC II, thereby 
inducing a SEA-specific Th2 response. However, further work is required to 
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understand the exact mechanism leading to this type of immune. The signaling 
cascades induced by ligation of CLRs are still poorly investigated. One recent paper 
describes that the binding of ligands to DC-SIGN induced the phosphorylation of 
Extracellular-signal regulated kinase (ERK 1/2) and Akt (protein kinase B), without 
the concurrent activation of p38 MAP Kinase (18). Furthermore, ligation of 
DC-SIGN has been shown to rigger the phosphorylation of phospholipase Cγ in 
dendritic cells. Since pathogens stimulate Th2 responses mainly via activation of 
ERK1/2, these data provide a molecular explanation for the ability of DC-SIGN-
interacting pathogens to preferentially evoke Th2-type immune responses (18). 
Agrawal and co-workers investigated the function of MAP Kinase-mediated 
signaling in the Th2 response to schistosomal SEA. They demonstrated that SEA is 
only a weak inducer of p38, but leads to the phosphorylation of ERK1/2 which 
suppresses the production of IL-12p70. As blocking of ERK1/2 did not result in an 
increase of IL-12p70, the authors assume that additional mechanisms regulate the 
suppression of IL-12p70 by SEA. Hence SEA-induced suppression of IL-12p70 
might be important in the generation of the Th2 response (18).  
 
The hygiene-hypothesis 
It is the long lasting Th2 immune response that is characteristic for helminth 
infections. Our immune system has been shaped over time by a continuous exposure 
to infectious agents suggesting a co-evolution of parasites and humans (35). A key 
feature of parasite infection is that the invaders are able to down-modulate the host’s 
immune response (35). The so-called “hygiene-hypothesis” claims that the lapse of 
parasite infection in our high-civilized world leads to a strong boost of allergies and 
autoimmune diseases (170). Knowledge on the molecular mechanisms in which 
helminths are able to modulate the immune response, as well as on the chemical 
nature of parasite-derived molecules, known to elicit an anti-inflammatory response, 
will help to understand the relevant immune processes in this challenging field of 
autoimmune disease and allergy.  
 
Schistosomiasis and HIV infection 
Furthermore, results achieved by studying the function of DC-SIGN in 
schistosomiasis might help to define the mechanisms involved in HIV infection, as 
DC-SIGN mediates the HIV infection in trans (52). Only a small number of studies 
is dealing with co-infection of HIV and schistosomes, but it has been already 
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described ten years ago that the secretion of eggs is clearly reduced in HIV patients 
(74). It has been further reported that S. mansoni co-infection with SHIV (simian-
human immunodeficiency virus) led to significant increase of viral replication (7). 
Intriguingly, S. mansoni co-infection enhanced the expression of Th2-associated 
cytokine responses and SHIV replication during both acute and chronic phases of 
SHIV infection. These results support the hypothesis that concomitant 
schistosomiasis up-regulates replication of immunodeficiency viruses in co-infected 
hosts, raising the possibility that parasite-infected individuals may also be more 
susceptible to acquisition of HIV-1 infection (20).  
 
The glycan-binding profile of L-SIGN 
The pathology of schistosome infection results mainly from granuloma in the liver 
due to entrapped eggs. Therefore, we have investigated, whether the C-type lectin 
L-SIGN which is present on liver resident antigen-presenting cells called LSECs 
(liver sinusoidal endothelial cells), is able to recognize schistosomal glycans. 
Remarkably, we could demonstrate that L-SIGN recognizes different glycan entities 
on egg glycoproteins and glycosphingolipids. Within egg glycoproteins of SEA, 
L-SIGN recognized primarily high-mannose type N-glycans and showed little 
interaction with fucose residues. It is known that, in addition to complex-type 
N-glycans, SEA contains hybrid-type N-glycans and high-mannose type N-glycans, 
but knowledge on the precise structures of the glycoprotein-glycans expressed in the 
egg stage or on SEA is still incomplete (166). In addition to the insights in the 
binding of L-SIGN to SEA, we were able to demonstrate for the first time that 
L-SIGN is able to interact with fucosylated glycans of schistosomal glycolipids. 
Whereas L-SIGN was found to bind only weakly to glycosphingolipids from 
cercarial or adult schistosomal stages, it specifically recognized a fucosylated 
fraction within egg glycosphingolipids in a fucose-dependent manner. Remarkably, 
L-SIGN exhibited a completely different binding pattern to schistosome glycan 
antigens than DC-SIGN, both in its interaction with SEA as well as in its binding 
profile to schistosomal glycosphingolipids. It would be of high interest to 
characterize the relative binding affinities of L-SIGN to high-mannose type glycans 
and glycan epitopes on egg glycosphingolipids, but such experiments could not be 
performed so far due to limited amounts of parasite material. Nevertheless, we could 
clearly identify the epitope bound by L-SIGN present in the egg glycolipids. Using a 
combination of several analytical techniques, we could demonstrate that F-LDN-F 
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represents a carbohydrate epitope mediating binding to L-SIGN. Intriguingly, 
F-LDN-F is also one epitope causing serological cross-reactivity of SEA with 
keyhole limpet-hemocyanine (KLH) (56).  
 
The role of glycans in the formation of liver granulomata 
In in vitro studies it could be demonstrated that beads coated with SEA or KLH are 
able to induce granuloma formation similar to schistosome eggs. The destruction of 
the integrity of the glycans by sodium periodate completely abolished the 
immunological and functional properties of SEA tested in these experiments (143). 
In a follow-up study from the same group the granulogenic property of SEA was 
referred to LN or LDN moieties, but not to fucosylated glycans (142). However, 
previous observations showed that sensitization with Lewis X containing 
neoglycoconjugates increases the size of the granulomata formed around SEA beads 
suggesting an opposite effect (68). Further work has to be performed to define 
precisely the role of the different glycans like LDN, F-LDN-F or Lewis X on SEA in 
their granulogenic activity. 
 
The Lewis X epitope 
The Lewis X epitope is widespread in the pathogen world. Already 4 decades ago the 
“molecular mimicry” hypothesis was developed, claiming that parasites share 
antigens with their host (24). The blood group antigen Lewis X occurs not only in 
schistosomes, but is, for example, also present on the ruminant parasite Haemonchus 
contortus and the human gastric pathogen Helicobacter pylori which is able to 
switch in its LPS the Lewis antigens on and off. Only the Lewis-positive variants are 
able to bind to DC-SIGN and this interaction is responsible for blocking the Th1 
response (11). Hence, this is an additional example to show how the binding to 
DC-SIGN modulates the balance between Th1 and Th2 response. Another case 
demonstrating how pathogens are able to shift the Th1/Th2 balance towards Th2 is 
provided by Mycobacterium tuberculosis which binds via its cell wall component 
ManLAM to DC-SIGN. ManLAM inhibits the TLR-induced maturation and induces 
the production of IL-10 (54). Altogether these studies provided clear evidence that 
the interaction of a pathogen with DC-SIGN may influence the fate of naïve T cells 
which might be a common mechanism for the mode of action of CLRs. 
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The binding specificities of L-SIGN and DC-SIGN  
It is interesting that the two highly related CLRs, such as DC-SIGN and L-SIGN, 
differ in their ability to recognize Lewis X. DC-SIGN, the CRD of which is strongly 
similar to the one of L-SIGN, hardly interacts with the total egg glycosphingolipids 
(104), and does not recognize the F-LDN-F epitope bound by L-SIGN. In contrast, 
DC-SIGN binds to fucosylated cercarial and adult glycosphingolipids which are 
hardly recognized by L-SIGN, as could be shown in this thesis. This differential 
binding mode of L-SIGN and DC-SIGN to fucosylated glycans has been also 
demonstrated by cell adhesion assays using a L-SIGN S363V mutant, containing a 
Valine residue present at a similar position as in DC-SIGN (151). In contrast to the 
wild-type L-SIGN, this mutant is able to recognize the fucosylated Lewis X 
carbohydrate epitope in analogy to DC-SIGN. Remarkably this mutant is no longer 
able to bind to F-LDN-F moieties on egg glycosphingolipids. Hence, we concluded 
that L-SIGN can recognize fucose-containing Lewis antigens, such as the Lewis 
antigens Lewis A and Lewis B, in a way similar to DC-SIGN, but recognizes 
multiply-fucosylated glycosphingolipid glycans via an alternative binding mode. It is 
astonishing that L-SIGN is able to interact with both high-mannose type glycans and 
differently fucosylated oligosaccharide ligands although comprising only one CRD. 
It has been reported several times, however that the binding pocket of a lectin may 
change depending on the structure of the glycan bound (75; 105). Maybe both C-type 
lectins, L-SIGN as well as DC-SIGN, use this described flexibility in their CRD to 
recognize different ligands.  
 
Detailed analyses of the interactions of defined glycoconjugates structures and their 
corresponding lectins are still in the beginning. But the results achieved so far show 
that parasites have co-evolved with us and are, therefore, successfully able to 
challenge our highly developed immune system. 
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4 Summary 
In this thesis the interactions of glycoconjugates, mainly glycosphingolipids, of the 
parasitic helminth Schistosoma mansoni with the human C-type lectins DC-SIGN 
(dendritic cell-specific ICAM-3 grabbing nonintegrin) and L-SIGN (liver/lymph 
node specific ICAM-3-grabbing nonintegrin) have been investigated. Since DC-
SIGN is known to act as a pathogen recognition receptor at an early stage of 
infection, glycolipids of cercariae, the human infectious larvae, have been isolated, 
and the glycan moieties have been released enzymatically. After separation into 
single glycan species via HPLC and subsequent structural characterization, 
neoglycolipids, carrying either Lewis X or pseudo-Lewis Y epitopes, were attached 
to a synthetic lipid anker by reductive amination. Solid phase assays using a 
recombinant chimeric DC-SIGN-Fc and binding studies with dendritic cells revealed 
that both carbohydrate species are recognized by DC-SIGN. Hence, pseudo-Lewis Y 
is the first parasite-specific ligand described for DC-SIGN so far. Molecular 
modeling further revealed that the observed binding of this schistosome-specific 
pseudo-Lewis Y motif to DC-SIGN is not directly compatible with the published 
model described for Lewis X. To fit pseudo-Lewis Y into the model, the orientation 
of the side chain of Phe313 in the secondary binding site of DC-SIGN was slightly 
changed, resulting in an energetically perfect stacking of Phe313 with the 
hydrophobic side of the galactose-linked fucose of pseudo-Lewis Y. We propose that 
pathogens such as S. mansoni may use this observed flexibility in the secondary 
binding site of DC-SIGN to target DCs, which may contribute to an escape from the 
host’s immune response. Furthermore, we were able to detect the presence of both 
Lewis X and pseudo-Lewis Y carbohydrate epitopes in glycolipids derived from 
cercarial S. mansoni excretory/secretory products, underlining their role in the 
immunobiology of schistosome infection. 
L-SIGN, i.e., the second human C-type lectin investigated, functions as antigen 
receptor on human liver sinusoidal endothelial cells. As the eggs of S. mansoni are 
the main inducers of a Th2 response, we were interested, as to whether glycans 
expressed on egg glycoproteins or egg glycolipids may play a role in this immune 
response, e.g., via binding to L-SIGN. Our data demonstrate that L-SIGN binds both 
schistosomal soluble egg antigens (SEA) and egg glycosphingolipids, and can 
mediate internalization of SEA by L-SIGN expressing cells. After treatment of SEA 
with endoglycosidase H to remove high-mannose type N-glycans, binding to L-SIGN 
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and internalization by L-SIGN expressing cells was clearly reduced, whereas 
defucosylation affected neither binding nor internalization. These data indicate that 
L-SIGN interacts with high-mannose type N-glycans of SEA. In parallel, L-SIGN 
was also tested for binding to egg glycosphingolipids. To this end, isolated 
glycolipids were fractionated and tested in binding studies using L-SIGN transfected 
cells. The results revealed that L-SIGN binds to a glycosphingolipid fraction 
containing fucosylated species with compositions of Hex1HexNAc5−7dHex3−6Cer, as 
confirmed by mass spectrometry. Subsequent linkage analyses, tandem mass 
spectrometry and molecular modeling studies demonstrated that binding of L-SIGN 
to the respective fucosylated egg glycosphingolipid species involves a Fucα1-
3GalNAcβ1-4(Fucα1-3)GlcNAc tetrasaccharide (F-LDN-F) at the non-reducing end 
of the carbohydrate chain. The L-SIGN “gain of function” mutant Ser363Val, which 
recognizes fucosylated Lewis antigens, did not bind to this fucosylated egg 
glycosphingolipid fraction, suggesting that L-SIGN exhibits different modes of 
binding to fucoses of egg glycosphingolipids and Lewis antigens. Taken together, 
our data indicate that L-SIGN recognizes both high-mannose type N-glycans and 
fucosylated carbohydrate motifs within schistosomal egg antigens, demonstrating 
that L-SIGN has a broad but specific glycan recognition profile.  
It is astonishing that such highly related C-type lectins differ in their carbohydrate 
recognition properties. Clearly, further studies are needed to gain deeper insights in 
the manifold ways parasitic glycans are able to bind to human C-type lectins and 
thereby influence the host’s immune response. 
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5 Zusammenfassung 
In der vorliegenden Arbeit wurden die Interaktionen von Glykokonjugaten, 
hauptsächlich Glykolipiden, des Humanparasiten Schistosoma mansoni mit den 
humanen C-typ Lektinen DC-SIGN (dendritic cell-specific ICAM-3 grabbing 
nonintegrin) und L-SIGN (liver/lymph node specific ICAM-3-grabbing nonintegrin) 
untersucht. Da DC-SIGN bereits im frühen Stadium der Infektion als 
Pathogenrezeptor fungiert, wurden Glykolipide aus S. mansoni Cercarien, den 
humaninfektiösen Larven, isoliert und deren Kohlenhydratanteile enzymatisch 
freigesetzt. Nach Auftrennung dieser Glykane durch verschiedene HPLC-Techniken 
wurden die resultierenden Fraktionen mittels MALDI-TOF-MS charakterisiert. Aus 
Glykanen, die das Lewis X [Galβ1-4(Fucα1-3)GlcNAc] oder das pseudo-Lewis Y 
Epitop [Fucα1-3Galβ1-4[Fucα3]GlcNAcβ-] tragen, wurden Neoglykolipide durch 
reduktive Aminierung an einen Lipidanker synthetisiert. Verschiedene 
Bindungsstudien mit rekombinantem, chimärem DC-SIGN-Fc und humanen 
dendritischen Zellen (DCs) zeigten, dass diese beiden Kohlenhydratepitope von 
DC-SIGN gebunden werden. Somit ist das schistosomenspezifische pseudo-Lewis Y 
Motiv der erste pathogenspezifische Ligand welcher für DC-SIGN entdeckt wurde. 
Durch molekulares Modellieren konnte gezeigt werden, dass zur Bindung von 
pseudo-Lewis Y die Orientierung der Seitenkette der Aminosäure Phe313 in der 
„secondary binding site“ von DC-SIGN leicht geändert werden musste, was jedoch 
in einer energetisch optimalen Bindung von Phe313 mit der hydrophobe Seite der an 
die Galaktose gebundenen Fucose des pseudo-Lewis Y resultierte. Daher wurde 
postuliert, dass Pathogene wie S. mansoni diese, auch von anderen Autoren 
beobachtete Flexibilität in der „secondary binding site“ von DC-SIGN, nutzen, um 
mit DCs zu interagieren, was zur Immunmodulation beitragen könnte. Des Weiteren 
konnte das Vorkommen von Lewis X und pseudo-Lewis Y Epitopen auf 
Glykolipiden, welche aus den exkretorischen/sekretorischen (E/S)- Produkten von 
Cercarien gewonnen wurden, aufgezeigt werden, was die Rolle dieser beiden Epitope 
in der Immunmodulation durch S. mansoni unterstreicht.  
L-SIGN, das zweite untersuchte humane C--typ Lektin, fungiert als Antigenrezeptor 
auf humanen sinusoidalen Endothelzellen der Leber (liver sinusoidal endothelial 
cells; LSECs). Da insbesondere die Eier von S. mansoni stark immunogen und ein 
Hauptauslöser der Th2 Immunantwort sind, interessierte uns, in wiefern deren 
Kohlenhydrate, vorliegend als Glykoproteine oder Glykolipide, in der 
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schistosomenspezifischen Immunantwort beteiligt sind, und welche 
Kohlenhydratepitope von L-SIGN gebunden werden. Die gewonnenen Daten 
belegen, dass L-SIGN sowohl Glykoproteine aus löslichen Eiantigenen (SEA, 
soluble egg antigens) als auch Glykolipide aus Eiern bindet. Des Weiteren konnte 
gezeigt werden, dass von L-SIGN gebundenes SEA auch in die Zelle internalisiert 
wird. Nach Behandlung von SEA mit Endoglykosidase H, welche 
oligomannosidische N-Glykane („high-mannose type“) abspaltet, waren jedoch keine 
Bindung an L-SIGN und folglich keine Internalisierung von SEA in L-SIGN- 
exprimierenden Zellen mehr beobachtbar. Im Gegensatz dazu wurde durch 
Flusssäure (HF) defucosyliertes SEA weiterhin von L-SIGN exprimierenden Zellen 
gebunden und vergleichbar schnell wie unbehandeltes SEA in diese Zellen 
internalisiert. Demzufolge bindet L-SIGN SEA nicht über ein fucosyliertes Epitop, 
sondern über oligomannosidische N-Glykane. Parallel zu den Glykoproteinen aus 
SEA wurden auch Glykolipide aus S. mansoni Eiern auf ihre Ligandenspezifität zu 
L-SIGN untersucht. Dazu wurden Glykolipide aus Eiern isoliert und über 
Kieselgelsäulen chromatographisch aufgetrennt. Die resultierenden 
Glykolipidfraktionen wurden in Bindungsstudien mit L-SIGN-exprimierenden Zellen 
eingesetzt. Diese führten zu dem Ergebnis, dass L-SIGN nur eine Glykolipidfraktion 
bindet. Diese enthält zahlreiche fucosylierte Spezies mit der massenspektrometrisch 
bestimmten allgemeinen Zusammensetzung Hex1HexNAc5−7dHex3−6Cer. Mit dieser 
Glykolipidfraktion durchgeführte Methylierungsanalysen zur Klärung der 
Kohlenhydratverknüpfungspositionen sowie Tandem Massenspektrometrie und 
molekulares Modellieren zeigten, dass die Bindung von L-SIGN zu dieser 
Glykolipidfraktion am nicht-reduzierenden Ende der Kohlenhydratkette das 
F-LDN-F Tetrasaccharid [Fucα1-3GalNAcβ1-4(Fucα1-3)GlcNAc] als minimalen 
Liganden benötigt. Die L-SIGN „gain of function” Mutante Ser363Val, welche auch 
fucosylierte Lewis Antigen erkennt, bindet jedoch diese F-LDN-F enthaltene 
Glykolipidfraktion nicht. Dies führte zu der Vermutung, dass L-SIGN über 
verschiedene Bindungsmodi für Fucosen in Ei Glykolipiden (F-LDN-F) und Fucosen 
in Lewis Antigenen verfügen muss. Zusammengefasst zeigen diese Daten zu 
L-SIGN, dass dieses Lektin sowohl oligomannosidische N-Glykane als auch 
fucosylierte Kohlenhydratepitope innerhalb der Schistosomen Eiantigene erkennt. 
Dies zeigt, dass L-SIGN zwar ein breites, aber zugleich auch ein 
kohlenhydratepitopspezifisches Ligandenprofil besitzt.  
Zusammenfassung 
 
 
 
 
 
 
 
 
 
 
 
89
Es ist bemerkenswert, dass zwei biochemisch so ähnliche und hoch konservierte 
C-typ Lektine wie DC-SIGN und L-SIGN dennoch in ihrer Ligandenspezifität 
variieren, welches in dieser Arbeit aufgezeigt werden konnte. Weitere Studien sind 
nötig, um die Funktionen dieser beiden Lektine innerhalb der vielfältigen 
Möglichkeiten, wie parasitische Glykane die Immunantwort des Wirtes beeinflussen 
können, aufzuklären. 
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